Adding LABAs to inhaled glucocorticoids for asthma.
作者信息
Szefler Stanley J, Busse William W
出版信息
N Engl J Med. 2011 Sep 29;365(13):1260-1; author reply 1261. doi: 10.1056/NEJMc1108965.
PMID:21991913
Abstract
摘要
相似文献
1
Adding LABAs to inhaled glucocorticoids for asthma.将长效β2受体激动剂添加到吸入性糖皮质激素中用于治疗哮喘。
N Engl J Med. 2011 Sep 29;365(13):1260-1; author reply 1261. doi: 10.1056/NEJMc1108965.
2
Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.评估在吸入性糖皮质激素中添加长效β2受体激动剂治疗哮喘的安全性。
N Engl J Med. 2011 Jun 30;364(26):2473-5. doi: 10.1056/NEJMp1104375.
3
Meeting the obligation to balance bioethics and clinical trial design in asthma.履行在哮喘病中平衡生物伦理学与临床试验设计的义务。
Am J Respir Crit Care Med. 2010 Apr 1;181(7):648-50. doi: 10.1164/rccm.200912-1891ED.
4
Use of long-acting beta-agonists and inhaled corticosteroids.
Ann Intern Med. 2006 Nov 7;145(9):710. doi: 10.7326/0003-4819-145-9-200611070-00023.
5
Beta-2 agonist discussions in asthma and a review of current data.哮喘中β-2激动剂的讨论及当前数据综述
Tuberk Toraks. 2011;59(2):205-12.
6
beta-Adrenergic bronchodilators and sudden death in asthmatics.β-肾上腺素能支气管扩张剂与哮喘患者的猝死
Drug Ther Bull. 1976 Mar 12;14(6):21-2.
7
[beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Dtsch Med Wochenschr. 2007 Mar 23;132(12):633; author reply 633-4. doi: 10.1055/s-2007-973592.
8
[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].吸入性糖皮质激素与长效β2受体激动剂之间的相互作用
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S386-9. doi: 10.1055/s-0029-1243047. Epub 2009 Nov 25.
9
Genetics, ethics, and the use of long-acting beta-adrenergics to treat asthma.遗传学、伦理学以及长效β-肾上腺素能药物在哮喘治疗中的应用
Am J Respir Crit Care Med. 2010 Apr 1;181(7):647-8. doi: 10.1164/rccm.200912-1890ED.
10
[Asthma therapy--too much or too little?].[哮喘治疗——过量还是不足？]
Dtsch Med Wochenschr. 1988 May 20;113(20):799-800. doi: 10.1055/s-2008-1067724.
Zotero 插件